US CDC Advisory Committee to Discuss Moderna and Janssen Vaccine Boosters on April 20-21

Discussion Scheduled on November 2-3 Regarding Pfizer Vaccine Administration for Children Aged 5-11

[Image source=Yonhap News]

[Asia Economy Reporter Gong Byung-sun] The advisory committee of the U.S. Centers for Disease Control and Prevention (CDC) is set to discuss booster shots for COVID-19 vaccines from pharmaceutical companies Moderna and Janssen.

According to CNN on the 8th (local time), the CDC's advisory committee, the Advisory Committee on Immunization Practices (ACIP), will hold a meeting on the 20th and 21st to discuss whether to approve booster shots for Moderna and Janssen's COVID-19 vaccines.

Currently, the United States has only approved booster shots for Pfizer's COVID-19 vaccine. U.S. health authorities have delayed approval for Moderna and Janssen booster shots, citing the need for more time to obtain and review clinical trial data.

The ACIP meeting will take place a few days after the meeting of the Vaccines and Related Biological Products Advisory Committee (VRBPAC), the advisory panel to the U.S. Food and Drug Administration (FDA). In the U.S., vaccination for the general public requires FDA approval followed by CDC recommendations.

ACIP is also scheduled to hold a meeting on November 2nd and 3rd to discuss whether to vaccinate children aged 5 to 11 with Pfizer's COVID-19 vaccine. Earlier, Pfizer applied for approval to vaccinate children aged 5 to 11 with its COVID-19 vaccine. The FDA advisory panel plans to review Moderna and Janssen booster shots on October 14th and 15th, followed by discussions on Pfizer's vaccine for children aged 5 to 11 on the 26th.

CNN interpreted this as meaning that vaccination for children under 11 will not begin before Halloween on October 31st. Some parents in the U.S. had hoped to vaccinate their 5 to 11-year-old children before Halloween, but it now appears this will be delayed.

This content was produced with the assistance of AI translation services.